Page 24 - BH-2-2

Brain & Heart Oxidative stress and neurological disorders

J Prev Alzheimers Dis. 2022;9(1):22-29. doi: 10.1016/j.jagp.2022.10.002
doi: 10.14283/jpad.2021.62 136. Rust R, Chien C, Scheel M, et al. Epigallocatechin gallate in
progressive MS: A randomized, placebo-controlled trial.
134. Losso JN, Finley JW, Karki N, et al. Pilot study of the tart
cherry juice for the treatment of insomnia and investigation Neurol Neuroimmunol Neuroinflamm. 2021;8(3):e964.
of mechanisms. Am J Ther. 2018;25(2):e194-e201. doi: 10.1212/NXI.0000000000000964
doi: 10.1097/MJT.0000000000000584 137. Qureshi MY, Patterson MC, Clark V, et al. Safety and
efficacy of (+)-epicatechin in subjects with Friedreich’s
135. Aarsland D, Khalifa K, Bergland AK, et al. A randomised
placebo-controlled study of purified anthocyanins on ataxia: A phase II, open-label, prospective study. J Inherit
cognition in individuals at increased risk for dementia. Am Metab Dis. 2021;44(2):502-514.
J Geriatr Psychiatry. 2023;31(2):141-151. doi: 10.1002/jimd.12285

Volume 2 Issue 2 (2024) 18 doi: 10.36922/bh.2704